FDA Launches AI Assistant Elsa to Accelerate Drug Reviews
The U.S. FDA has officially launched its AI assistant Elsa, designed to streamline drug approval processes while maintaining data security. The tool, deployed ahead of schedule, assists with clinical reviews, inspections, and document processing.
DAMN
0
